Evaluating probiotics for the prevention of ventilator-associated pneumonia: a randomised placebo-controlled multicentre trial protocol and statistical analysis plan for PROSPECT

INTRODUCTION: Ventilator-associated pneumonia (VAP) is the most common healthcare-associated infection in critically ill patients. Prior studies suggest that probiotics may reduce VAP and other infections in critically ill patients; however, most previous randomised trials were small, single centre...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:BMJ Open
Main Authors: Johnstone, Jennie, Heels-Ansdell, Diane, Thabane, Lehana, Meade, Maureen, Marshall, John, Lauzier, Francois, Duan, Erick Huaileigh, Zytaruk, Nicole, Lamarche, Daphnee, Surette, Michael, Cook, Deborah J
Formato: Artigo
Idioma:Inglês
Publicado: BMJ Publishing Group 2019
Assuntos:
Intensive Care
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6596980/
https://ncbi.nlm.nih.gov/pubmed/31227528
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2018-025228
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares